Live Session
Bridging the Discovery-to-Translational Gap in Spatial Biology
Oct 21, 2025
9:00 am PDT / 12:00 pm EDT
Spatial biology is uncovering new biomarker candidates, yet a major challenge remains: how to move from broad high-plex discovery to clinically relevant panels suitable for translational and clinical research workflows.
Join this interactive live session for direct Q&A with two spatial biology experts and see how capturing more channels per imaging round enables you to perform high-plex discovery, then streamline to single-round panels optimized for large cohort studies.
We’re excited to welcome Zhihong Chen, Ph.D., CTO of OCCAM Immune, Icahn School of Medicine, as our guest speaker. Dr. Chen will discuss how to design effective multiplex panels for clinical and translational research, integrate Orion imaging with complementary multi-omics datasets, and apply approaches for large-scale data analysis and interpretation.
Join us for a discussion on:
- What clinical insights researchers are gaining from spatial biology studies
- The top challenges to implementing spatial biology in translational and clinical settings
- How Orion supports a seamless path from discovery panels to single-round clinical panels
This interactive format lets attendees ask questions live and learn how Orion is being applied in translational research today.
Speaker
Zhihong Chen, PhD
CTO, OCCAM Immune, at Icahn School of Medicine, Mount Sinai Hospital, New York
Dr. Zhihong (Z) Chen is the Chief Technology Officer. Dr. Chen holds a PhD in Neuroimmunology, which he earned from the University of Ottawa, Canada. His expertise spans a wide range of cutting-edge techniques, which he skillfully applies to address complex scientific inquiries. Dr. Chen is dedicated to proactive approaches in seeking out challenging problems. He has a genuine passion for innovation and is enthusiastic about introducing and exploring novel, state-of-the-art technology platforms in an effort to expand our immuno-assay portfolio at Occam.
Speaker
Tad George, PhD
Senior VP, Biology R&D
RareCyte Inc.
Tad has over 15 years of startup experience dedicated to creating scientific markets for novel instrumentation platforms that span basic research, drug discovery and clinical applications. Prior to joining RareCyte, Tad has held similar positions at Biodesy, Inc. and DVS Sciences, and was Director of Biology at Amnis Corporation. Tad completed his B.A. in Biochemistry from the Univ. of Texas at Austin, Ph.D. in Immunology from UT Southwestern Medical Center at Dallas, and post-doctoral training at Immunex Corp. in Seattle.
